Regen Therapy CEO Sanjiv Lal to appear on Next Level CEO TV

Sanjiv Lal, CEO and co-founder of Regen Therapy, will appear on Next Level CEO TV to discuss how regenerative medicine can scale responsibly. The episode will highlight secretome science, cellular signaling and the infrastructure needed to separate credible science from hype.

Why it matters: - Regen Therapy’s appearance on a business-and-education platform gives regenerative medicine a broader audience beyond clinical and scientific circles. - Lal’s focus on manufacturing, physician education, clinical frameworks and scientific collaboration points to the operational hurdles that can determine whether regenerative medicine reaches scale. - The episode also frames the field around evidence and credibility at a time when hype can outpace validated outcomes.

What happened: - Sanjiv Lal, CEO and co-founder of Regen Therapy, is set to appear on Next Level CEO TV. - The episode will feature Lal discussing how regenerative medicine can move from promising science toward responsible, scalable healthcare. - Next Level CEO is hosted by Daymond John and is designed to spotlight entrepreneurs, industry leaders and top performers. - The series will distribute Lal’s episode soon through Inside Success Network platforms. - More information about the episode is available in this link.

The details: - Lal’s episode will explore secretome science and cellular signaling. - The conversation will address why manufacturing standards matter in regenerative medicine. - The episode will also cover physician education as a key requirement for adoption. - Lal will discuss the need for clinical frameworks to guide responsible use. - Scientific collaboration is presented as another requirement for advancing the field. - The show positions itself as an educational series built around leadership lessons and strategies from successful executives.

Between the lines: - The appearance suggests Regen Therapy is aiming to build trust and visibility around a category that still needs clearer standards and broader professional understanding. - Framing the discussion around infrastructure, not just science, signals that commercialization and credibility remain central challenges. - The episode’s focus on separating credible science from hype reflects a broader industry need for better filtering of claims and outcomes.

What’s next: - Lal’s episode will be released soon on Inside Success Network distribution platforms. - Viewers who want early details can use the show link provided in the announcement. - The episode may help position Regen Therapy and Lal as part of the broader conversation about practical regenerative medicine adoption.

The bottom line: - The upcoming TV appearance is designed to turn regenerative medicine into a more understandable, operationally grounded conversation for a mainstream business audience.